CNS Pharmaceuticals, Inc. (CNSP) › Operating Cash FlowCNS Pharmaceuticals, Inc. (CNSP) — Operating Cash FlowAnnual figures by period end, from SEC filings.2018-12-31: -$716.4K2019-12-31: -$3.55M2020-12-31: -$7.32M2021-12-31: -$13.54M2022-12-31: -$10.56M2023-12-31: -$14.14M2024-12-31: -$17.11M2025-12-31: -$13.81M-$13.81M2018-12-31Operating Cash Flow (USD)2025-12-31Period endedOperating Cash FlowChange YoYSource filing2025-12-31-$13.81M—2026-03-31From 2025-01-012024-12-31-$17.11M—2026-03-31From 2024-01-012023-12-31-$14.14M—2025-03-31From 2023-01-012022-12-31-$10.56M—2024-04-01From 2022-01-012021-12-31-$13.54M—2023-03-31From 2021-01-012020-12-31-$7.32M—2022-03-03From 2020-01-012019-12-31-$3.55M—2021-02-12From 2019-01-012018-12-31-$716.4K—2020-03-12From 2018-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)